Cargando…

Improving community participation in clinical trials in Ghana; factors to consider

INTRODUCTION: Clinical trials are an essential part of drug and vaccine development, as well as the development of new biomedical devices, and medical procedures. Successful enrolment of human volunteers is important to the success of any clinical trial anywhere around the globe. Enrolment is howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Appeaning, Mark, Owusu-Asante, Helen, Kwofie, Samuel, Arhin, George, Asamoah, Andrew Oppong, Ali, Tawfic, Amponsah, Reginald Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574414/
https://www.ncbi.nlm.nih.gov/pubmed/36262802
http://dx.doi.org/10.1016/j.conctc.2022.101012
_version_ 1784811100528705536
author Appeaning, Mark
Owusu-Asante, Helen
Kwofie, Samuel
Arhin, George
Asamoah, Andrew Oppong
Ali, Tawfic
Amponsah, Reginald Roland
author_facet Appeaning, Mark
Owusu-Asante, Helen
Kwofie, Samuel
Arhin, George
Asamoah, Andrew Oppong
Ali, Tawfic
Amponsah, Reginald Roland
author_sort Appeaning, Mark
collection PubMed
description INTRODUCTION: Clinical trials are an essential part of drug and vaccine development, as well as the development of new biomedical devices, and medical procedures. Successful enrolment of human volunteers is important to the success of any clinical trial anywhere around the globe. Enrolment is however affected by a number of factors including knowledge, attitudes, and perceptions (KAPs). We aimed to determine factors that are deemed important in improving participation in clinical trials within a Ghanaian community. METHOD: This was a cross-sectional study that employed a structured questionnaire within the New Juaben South Municipal Assembly (NJSMA). Participants who were 18 years and above were included in this study. There were a total of 639 participants in this study. Participants’ demographics were collected and various questions were asked to assess their KAP towards participation in clinical trials. RESULTS: The mean age of participants was 29.03 ± 8.95 years, there were more males (51.96%) than females, 42.35% had tertiary education, 38.03% were artisans, 74.80% were Christians and 14.40% had previously participated in a clinical trial. Participants had average knowledge about clinical trials (CT) with a mean score of 7.56 ± 1.76 (63%). A significant association between knowledge levels and education was observed (χ2 = 100.3, p < 0.0001). Helping in advancing the medical knowledge was the key reason for participation in CT while mistrust of the medical system was the key setback in participation in CT. There was a generally positive attitude and a neutral perception towards participation in CTs. CONCLUSION: Groups intending to conduct CT should highlight the benefits of CT and address the perception of mistrust in the conduct of CTs in their education and sensitization programs before initiation of CTs in Ghana.
format Online
Article
Text
id pubmed-9574414
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95744142022-10-18 Improving community participation in clinical trials in Ghana; factors to consider Appeaning, Mark Owusu-Asante, Helen Kwofie, Samuel Arhin, George Asamoah, Andrew Oppong Ali, Tawfic Amponsah, Reginald Roland Contemp Clin Trials Commun Article INTRODUCTION: Clinical trials are an essential part of drug and vaccine development, as well as the development of new biomedical devices, and medical procedures. Successful enrolment of human volunteers is important to the success of any clinical trial anywhere around the globe. Enrolment is however affected by a number of factors including knowledge, attitudes, and perceptions (KAPs). We aimed to determine factors that are deemed important in improving participation in clinical trials within a Ghanaian community. METHOD: This was a cross-sectional study that employed a structured questionnaire within the New Juaben South Municipal Assembly (NJSMA). Participants who were 18 years and above were included in this study. There were a total of 639 participants in this study. Participants’ demographics were collected and various questions were asked to assess their KAP towards participation in clinical trials. RESULTS: The mean age of participants was 29.03 ± 8.95 years, there were more males (51.96%) than females, 42.35% had tertiary education, 38.03% were artisans, 74.80% were Christians and 14.40% had previously participated in a clinical trial. Participants had average knowledge about clinical trials (CT) with a mean score of 7.56 ± 1.76 (63%). A significant association between knowledge levels and education was observed (χ2 = 100.3, p < 0.0001). Helping in advancing the medical knowledge was the key reason for participation in CT while mistrust of the medical system was the key setback in participation in CT. There was a generally positive attitude and a neutral perception towards participation in CTs. CONCLUSION: Groups intending to conduct CT should highlight the benefits of CT and address the perception of mistrust in the conduct of CTs in their education and sensitization programs before initiation of CTs in Ghana. Elsevier 2022-10-03 /pmc/articles/PMC9574414/ /pubmed/36262802 http://dx.doi.org/10.1016/j.conctc.2022.101012 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Appeaning, Mark
Owusu-Asante, Helen
Kwofie, Samuel
Arhin, George
Asamoah, Andrew Oppong
Ali, Tawfic
Amponsah, Reginald Roland
Improving community participation in clinical trials in Ghana; factors to consider
title Improving community participation in clinical trials in Ghana; factors to consider
title_full Improving community participation in clinical trials in Ghana; factors to consider
title_fullStr Improving community participation in clinical trials in Ghana; factors to consider
title_full_unstemmed Improving community participation in clinical trials in Ghana; factors to consider
title_short Improving community participation in clinical trials in Ghana; factors to consider
title_sort improving community participation in clinical trials in ghana; factors to consider
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574414/
https://www.ncbi.nlm.nih.gov/pubmed/36262802
http://dx.doi.org/10.1016/j.conctc.2022.101012
work_keys_str_mv AT appeaningmark improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider
AT owusuasantehelen improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider
AT kwofiesamuel improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider
AT arhingeorge improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider
AT asamoahandrewoppong improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider
AT alitawfic improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider
AT amponsahreginaldroland improvingcommunityparticipationinclinicaltrialsinghanafactorstoconsider